This is the authors' abstract. We don't add key points for this paper.
CRISPR-Cas9 based genome editing combined with single-cell sequencing enables the tracing of the history of cell divisions, or cellular lineage, in tissues and whole organisms. While standard phylogenetic approaches may be applied to reconstruct cellular lineage trees from this data, the unique features of the CRISPR-Cas9 editing process motivate the development of specialized models that describe the evolution of CRISPR-Cas9 induced mutations. Here, we introduce the star homoplasy model, a novel evolutionary model that constrains a phylogenetic character to mutate at most once along a lineage, capturing the non-modifiability property of CRISPR-Cas9 mutations. We derive a combinatorial characterization of star homoplasy phylogenies by identifying a relationship between the star homoplasy model and the binary perfect phylogeny model. We use this characterization to develop an algorithm, Startle (Star tree lineage estimator), that computes a maximum parsimony star homoplasy phylogeny. We demonstrate that Startle infers more accurate phylogenies on simulated CRISPR-based lineage tracing data compared to existing methods; particularly on data with high amounts of dropout and homoplasy. Startle also infers more parsimonious phylogenies with fewer metastatic migrations on a lineage tracing dataset from mouse metastatic lung adenocarcinoma. Code availability Software is available at https://github.com/raphael-group/startle
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sashittal et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: